Ten News Live

Premier Conference to Highlight Gasification, Syngas and Methanol Industries

Business Wire India

The 2016 Gasification and Syngas Technologies Conference will highlight emerging markets, detail advances in syngas and methanol production, and provide the latest updates on global projects and important trends in biomass and waste gasification.

 

The Gasification and Syngas Technologies Council (GSTC), the world’s premier trade association for the syngas and gasification industries, released the preliminary conference program today. GSTC is hosting the event Oct. 16-19 in Vancouver, Canada.

 

The annual conference is the gasification and syngas industries’ largest and most prestigious event — attracting speakers, participants and media from the Americas, Asia and Europe. This year’s conference will have a special focus on methanol after GSTC formed a strategic partnership with the Methanol Institute.

 

“We’re excited to be bringing the industries’ top leaders and foremost experts together at our newly expanded conference,” said Alison Kerester, GTC’s Executive Director. “We’ve broadened our focus to include methanol, all syngas-producing technologies, and new syngas markets, such as syngas for fuel cells. This will be the ideal place to meet key people in each of these industries.”

 

Formerly known as the Gasification Technologies Council, the association expanded this year to encompass the syngas production, processing and conversion industries. This year’s conference has broadened as well.

 

Among the topics to be covered in detail:

 

  • Emerging markets for methanol
  • Methanol plant expansion to increase profitability
  • Syngas to liquid fuels
  • Syngas production
  • Syngas for fuel cells
  • Syngas to hydrogen, ammonia/urea and derivatives
  • Syngas cleaning and conditioning
  • Waste and biomass to energy
  • Technology and equipment advances
  • Updates on global projects

The preliminary agenda can be found at www.gasification-syngas.org/events/2016-conference.

 

Corporate sponsors of the conference include Synthesis Energy Systems and CB&I.

 

To learn more about the conference, or to join the newly expanded GSTC, visit www.gasification-syngas.org.

 

About the Gasification and Syngas Technologies Council

 

The Gasification and Syngas Technologies Council (GSTC) promotes the role that gasification and syngas technologies play in helping improve the energy, power, chemical, refining, fuel and waste management industries. GSTC encourages the use of economically competitive and environmentally conscious technologies to produce electricity, fuels, chemicals, fertilizers, substitute natural gas, and hydrogen from a variety of feedstocks, including coal, petroleum coke, natural gas, refinery liquids, biomass and waste.

 

Learn more at www.gasification-syngas.org.

 

 

 

 

Two Best Friends Finally Decided to Self Publish their ‘Untitled’ Story after a Long Wait of 7 Years

Business Wire India
Manik Nath and Ashish Malviya, two best friends, who have been friends from long time, but now are separated by distance of seas, finally released their book, Untitled – Every Life Needs a Name, in India, through Educreation Publishing, India's Number 1 Self Publishing Website.

Manik Nath is presently in Johannesburg, South Africa, and Ashish Malviya presently lives in Pune, but both of them have an inbound friendship which enables them to write and release their wonderful feelings in the form of a book.


'Untitled – Every Life Needs a Name' is basically a light read. The book is full of silly doings and funny acts of two teenage friends over love and otherwise. The core of the story revolves around the friendship of two best friends and their teenage love stories. The story will leave a nice smile on the readers as they can relate some part of the story or other with their own lives in a positive way. A reader may find himself laughing on and on while going through the comic and funny instances throughout the book.

The book has received a good response since its release; speaking about their experiences, Manik and Ashish told, "The feedback from a few readers is that the book passes a message friendship is the key to a lot of things in life."

The publication of 'Untitled' is a true success of the concept of self publishing in India. Through the self publishing platforms like Educreation Publishing, the authors can not only live their dreams but also can reach the readers with their works.

Speaking over directives and steps towards their first book, Manik and Ashish said, "After finishing the book, it took almost 7 years before the book could finally be published. Initially, we sent the script to many traditional publishers and got rejected, with one of the publishers we came very close to get published, but the publisher wanted us to modify the story to suit something which the publisher thought would be a hit in the market; however, we as authors were not ready to do this. We gave up hope at that time. After 7 years, we realized that the publishing scenario in India has changed and esteemed self publishing houses like Educreation have come forward to help new authors like us. We approached a few self publishing houses including Educreation. The commitment shown by the management team of Educreation in removing the publishing hurdles, and the dedication shown by the publishing team of Educreation helped our dream come true. We thank the team of Educreation for helping new authors like us who wanted to come in the Indian book market and for helping us realize our dreams."

With these words from two emerging Indian authors, no doubt Educreation Publishing is worth for its rank of Number 1 Self Publishing Website in India. By using self publishing services of Educreation Publishing, any emerging author can self publish his book in India, conveniently and professionally. The book published from Educreation Platform is made available internationally.

'Untitled – Every Life Needs a Name' is also available in more than 100 countries and in more than 39,000 locations as Paperback and eBook. In India, the book is available on Amazon, Flipkart, BooksCamel.com, Infibeam, Paytm, Rediff Books, Google Playstore, Kindle and many other places.

You may grab your own copy from the following links:

Educreation Store: http://www.educreation.in/store/untitled-manik-nath-ashish-malviya.html

BooksCamel: http://www.bookscamel.com/index.php?route=product/product&product_id=114

You may read more about the authors here:

Manik Nath: http://www.educreation.in/author/maniknath/

Ashish Malviya: http://www.educreation.in/author/ashishmalviya/

Photo Caption: Manik Nath and Ashish Malviya with their book, Untitled

TAGRISSO (OSIMERTINIB) SHOWS CLINICAL ACTIVITY IN PATIENTS WITH LEPTOMENINGEAL DISEASE FROM LUNG CANCER

Business Wire India

AstraZeneca announced clinical and safety data for Tagrisso (osimertinib) in patients with leptomeningeal (LM) disease, a complication of epidermal growth factor receptor (EGFR) mutation-positive advanced non-small cell lung cancer (NSCLC),1 where cancer cells spread to the cerebrospinal fluid (CSF). LM is a devastating disease associated with advanced lung cancer.

 

The updated BLOOM Phase I trial results, presented at the American Society of Clinical Oncology (ASCO) annual meeting, showed that irrespective of T790M status of patients, osimertinib led to a change in MRI signal intensity indicative of a reduction in central nervous system (CNS) lesions. 1

 

Data from 21 patients treated with osimertinib 160mg once daily showed intracranial radiological improvement in seven patients, neurological function improvement in five patients, and clearance of tumour cells from the CSF at two consecutive visits in two patients.1 None of the 21 patients treated with osimertinib received concomitant radiotherapy or intrathecal chemotherapy. Fifteen patients remained on treatment at data cut-off (10 March 2016), of whom seven had been on treatment for more than nine months.1

 

Further data from the BLOOM study showed that osimertinibcrossed the blood-brain barrier. In six of nine patients, a greater than 50% decrease in EGFR mutation level was observed in the CSF up to cycle 9, day 1 of treatment, with a sustained reduction observed in five. These results support previously reported preclinical data demonstrating that osimertinib crosses the blood-brain barrier.2

 

Dr James CH Yang, from the National Taiwan University Hospital and National Taiwan University Cancer Centre, Taipei, said: “Leptomeningeal disease carries a devastating prognosis, so the safety, tolerability and activity profile seen with osimertinib is encouraging. In the BLOOM study, we saw a decrease in central nervous system lesions in patients with leptomeningeal disease, with accompanying neurological improvement. The results build on previous findings with osimertinib in preclinical and clinical studies and provide evidence of the potential of osimertinib in difficult-to-treat patients who have central nervous system metastases.”

 

In leptomeningeal disease, cancer cells spread to the membranes surrounding the brain and spinal cord. The disease is currently treated with systemic or intrathecal chemotherapy, whole-brain radiation therapy or EGFR tyrosine kinase inhibitors (TKIs), with median overall survival of 4.5-11 months.3,4 However, most currently-available EGFR-TKIs have limited ability to cross the blood-brain barrier to effectively treat or prevent brain metastases.5-7

 

Osimertinib 160mg was associated with a manageable tolerability profile over treatment periods up to 11 months. The most common adverse events reported by patients were diarrhoea (58% overall; 5% ≥Grade 3), nausea (48% overall; 0% ≥Grade 3) and rash (43% overall; 0% ≥Grade 3). There were no reported cases of interstitial lung disease, hyperglycaemia or QT prolongation.

 

Osimertinibrecently received accelerated approval as the first indicated treatment for patients with EGFR T790M mutation-positive locally advanced/metastatic NSCLC in the US, EU, Japan and Israel. Osimertinib is also approved in South Korea in the same indication.

 

AstraZeneca is committed to exploring the full potential of osimertinib in patients with lung cancer, including adjuvant and locally advanced/metastatic first-line EGFRm settings, in patients with and without brain metastases, and in those with leptomeningeal disease.8

 

– ENDS –

 

NOTES TO EDITORS

 

About Non-Small Cell Lung Cancer (NSCLC)

 

Lung cancer is the leading cause of cancer death among both men and women, accounting for about one-third of all cancer deaths and more than breast, prostate and colorectal cancers combined.9 Patients who have the EGFRm form of NSCLC, which occurs in 10-15% of NSCLC patients in Europe10 and 30-40% of NSCLC patients in Asia,11 are particularly sensitive to treatment with currently available EGFR-TKIs, which block the cell signalling pathways that drive the growth of tumour cells.12 However, tumours almost always develop resistance to treatment, leading to disease progression.13 In approximately two-thirds of patients treated with approved EGFR-TKIs such as gefitinib and erlotinib, this resistance is caused by the secondary mutation, T790M.13

 

About leptomeningeal disease

 

In leptomeningeal disease, cancer cells spread to the membranes surrounding the brain and spinal cord. It is a complication that affects 3-5% of patients with NSCLC14, and 9% of those with EGFRm NSCLC.15 Treatment is challenging due to poor penetration of the blood-brain barrier by most EGFR-TKI therapies, making it difficult for drugs to reach the brain and spinal cord. 5-7 Average survival in patients with EGFRm NSCLC and leptomeningeal disease is 4.5 to 11 months.3-4 In a recently reported “real-world” retrospective analysis of patients with EGFRm NSCLC treated with EGFR-TKIs, overall survival was approximately 30 months.16

 

About osimertinib

 

Osimertinib 80mg once-daily tablet is the first medicine indicated for the treatment of adult patients with locally advanced or metastatic EGFR T790M mutation-positive NSCLC. Non-clinical in vitro studies have demonstrated that osimertinibhas high potency and inhibitory activity against mutant EGFR phosphorylation across the range of clinically relevant EGFR and T790M mutant NSCLC cell lines with significantly less activity against EGFR in wild-type cell lines.17

 

Osimertinib is being compared with platinum-based doublet chemotherapy in the confirmatory AURA3 Phase III study in patients with EGFR T790M mutation-positive, locally advanced or metastatic NSCLC who have progressed after EGFR-TKI therapy.18 It is also being investigated in the adjuvant and metastatic first-line settings,19,20 including in patients with and without brain metastases, in leptomeningeal disease,8 and in combination treatment.21

 

About AstraZeneca in Oncology

 

AstraZeneca has a deep-rooted heritage in Oncology and offers a quickly growing portfolio of new medicines that has the potential to transform patients’ lives and the Company’s future. With at least 6 new medicines to be launched between 2014 and 2020, and a broad pipeline of small molecules and biologics in development, we are committed to advance New Oncology as one of AstraZeneca’s six Growth Platforms focused on lung, ovarian, breast and blood cancers. In addition to our core capabilities, we actively pursue innovative partnerships and investments that accelerate the delivery of our strategy as illustrated by our investment in Acerta Pharma in haematology.

 

By harnessing the power of four scientific platforms — immuno-oncology, the genetic drivers of cancer and resistance, DNA damage repair and antibody drug conjugates — and by championing the development of personalised combinations, AstraZeneca has the vision to redefine cancer treatment and one day eliminate cancer as a cause of death.

 

About AstraZeneca

 

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology – as well as in infection and neuroscience. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com

 

References

 

1Yang JCH, et al. Osimertinib activity in patients (pts) with leptomeningeal (LM) disease from non-small cell lung cancer (NSCLC): updated results from BLOOM, a Phase I study. Abstract 9002 [Oral Presentation]. Presented at the annual meeting of the American Society of Clinical Oncology, 3-7 June 2016, Chicago, USA.

 

Ballard P, et al. Preclinical activity of AZD9291 in EGFR-mutant NSCLC brain metastases. Presented at the World Congress on Lung Cancer, 6-9 September 2015. Denver, Colorado, USA.

 

Liao BC et alEpidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis. J Thorac Oncol. 2015;10(12):1754-61.

 

4 Umemura S et alClinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study GroupLung Cancer. 2012;77(1):134-9.

 

5 European Medicines Agency CHMP assessment report for Giotrif. 2013.

 

De Vries NA et alRestricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP. Invest New Drugs. 2012;30(2):443-9.

 

Zhao J et alCerebrospinal fluid concentrations of gefitinib in patients with lung adenocarcinoma. Clin Lung Cancer. 2013 Mar;14(2):188-93.

 

National Institutes of Health. Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer (BLOOM). Available at: https://clinicaltrials.gov/ct2/show/NCT02228369?term=AZD9291+brain+met&rank=1. Accessed May 2016.

 

GLOBOCAN (2012). Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed May 2016.

 

10 Szumera-Ciećkiewicz A, et al. EGFR mutation testing on cytological and histological samples in non-small cell lung cancer: a Polish, single institution study and systematic review of European incidenceInt J Clin Exp Pathol. 2013;6:2800-12.

 

11 Ellison G, et al. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samplesJ Clin Pathol. 2013;66:79-89.

 

12 Langer CJ, et al. Epidermal Growth Factor Receptor Inhibition in Mutation-Positive Non-Small-Cell Lung Cancer: Is Afatinib Better or Simply Newer? Journal of Clinical Oncology. 2013;31(27);3303-3305.

 

13 Yu HA, et al. Analysis of Tumour Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung CancerClin Cancer Research:2013:19(8):2240-2246.

 

14 Chamberlain MC, et alCarcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy.Arch Neurol. 1998;55(4):506-12.

 

15 Kuiper JL, et al. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysisLung Cancer. 2015;89(3):255-61.

 

16 Inoue A, et alCharacteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients. Jpn J Clin Oncol. 2016;pii: hyw014 [Epub ahead of print].

 

17 Cross DAE, et al. AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung CancerCancer Discov. 2014;4:1046-61.

 

18 National Institutes of Health. AZD9291 Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (AURA3). Available at: https://clinicaltrials.gov/ct2/show/NCT02151981?term=AURA3&rank=1. Accessed May 2016.

 

19 National Institutes of Health. AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy (ADAURA). Available at:https://www.clinicaltrials.gov/ct2/show/NCT02511106?term=AZD9291+Versus+Placebo+in+Patients&rank=1. Accessed May 2016.

 

20 National Institutes of Health. AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLAURA). Available at https://clinicaltrials.gov/ct2/show/NCT02296125?term=FLAURA&rank=1. Accessed May 2016.

 

21 National Institutes of Health. AZD9291 in Combination With Ascending Doses of Novel Therapeutics. Available at:https://www.clinicaltrials.gov/ct2/show/NCT02143466?term=azd9291&rank=1. Accessed May 2016.

 

– ENDS –

 

 

Andersen Global Takes Initial Step in Expanding Footprint in Canada

Business Wire India

Andersen Global is pleased to announce that we are now collaborating with SdM Chartered Professional Accountants, Inc. in Canada. SdM is the first of several firms that are expected to take this initial step toward a more formal relationship with Andersen Global through a Collaboration Agreement. Although SdM will not be a full-fledged member firm, they will be collaborating with Andersen Tax in the U.S., and other Andersen Global member firms throughout the world, to provide best-in-class service to their clients.

 

“SdM exemplifies the ‘Andersen’ qualities we look for in our colleagues and we look forward to working with them more closely to meet our clients’ needs in Canada,” said Mark Vorsatz, CEO of Andersen Tax.

 

Simon Davari, Founding Partner at SdM shared, “We’ve worked with Andersen Tax over the past several years and this is the logical next step in both our relationship with Andersen Tax and our growth as a firm.”

 

SdM, based in Montreal, Quebec, provides a wide range of services including tax, advisory, and international tax with an emphasis on serving the unique needs of multinationals and growing companies. SdM strives for excellence in delivering solutions tailored to the unique needs and business model of the client. The SdM team is led by partners Simon Davari, Sanaz Moshaver and Patrick Coutu.

 

 

 

 

Waldorf Astoria Set to Open in the Middle East’s Leading Financial District

Business Wire India

Waldorf Astoria Hotels & Resorts, Hilton Worldwide‘s (NYSE:HLT) luxury brand of iconic landmark hotels, announced the signing of a management agreement with Ward Holdings to open a property in the Middle East’s leading gateway for capital and investment, Dubai International Financial Centre (DIFC).

 

Waldorf Astoria Dubai International Financial Centre is expected to begin welcoming guests in Autumn 2017, and will offer travellers timeless luxury and exceptional experiences in this bustling area of Dubai. The hotel will join a prestigious portfolio of 25 Waldorf Astoria properties operating in diverse global destinations such as Amsterdam, Beijing and New York.

 

“Sound fundamentals underpin our luxury story in the Middle East, where we have seen exceptional growth in locations tailored for both leisure and business travellers,” said Carlos Khneisser, vice president of development, Middle East and North Africa for Hilton Worldwide. “I have long admired the role DIFC plays in the world of international investment, benefitting from its east meets west location and world-class trading framework. As an iconic luxury brand originating from New York, another centre of global finance, I am delighted that we will welcome Waldorf Astoria to this international hub.”

 

Forming part of a mixed-use residential, retail and office-space development, Waldorf Astoria Dubai International Financial Centre will feature 247 guest rooms, as well as a range of upscale dining options, spa and wellness facilities. Significant events space will include a grand ballroom and a further four meeting rooms, designed for social occasions and corporate events.

 

Mr. Shehab Gargash, representative of the property owners, said, “Our partnership with Hilton Worldwide for the management of this truly exceptional property under the Waldorf Astoria luxury brand, at the heart of one of the world’s most dynamic financial centres, will significantly enrich the high-end hospitality and dining environments in DIFC. It will offer business, as well as leisure travellers, new and compelling luxurious living option at the heart of Dubai’s major financial, business and commercial centres, with easy access to the largest shopping malls and a wide range of restaurants and entertainment.”

 

Dubai enjoys a prestigious reputation as a destination of choice for business and leisure travellers – with its array of upscale tourist attractions, attractive climate as well as being a hub for business and commerce in the region. The upcoming Dubai Expo 2020 will shine a year-long spotlight on the Emirate as more than 25 million visitors are expected to attend.

 

John T.A. Vanderslice, global head, Waldorf Astoria Hotels & Resorts, said, “Our luxury presence in the Middle East is further bolstered by this superb addition in DIFC, joining the UAE’s Dubai Palm Jumeirah and Ras Al Khaimah where we already welcome guests with True Waldorf Service. In the coming years we are set to open in new locations across the world, from Beverly Hills to Bangkok and Bali – as Waldorf Astoria continues to set the standard for international luxury travel.”

 

Across the Middle East, Hilton Worldwide is rapidly expanding its portfolio of mid-market, upscale and luxury properties within its distinct portfolio of brands. In 2015, notable milestones included the opening of three Hilton Garden Inn hotels in Dubai; the signing of an agreement for the first Hampton by Hilton in the Middle East; as well as confirmation of the first Curio, a Collection by Hilton for Dubai with The Rosemont Hotel & Residences. Waldorf Astoria Dubai International Financial Centre will be located on Al Saada Street, opposite DIFC and approximately 10 kilometres from Dubai International Airport (DXB).

 

From arrival to departure, guests will be embraced by the hotel's inspirational environments and welcomed by True Waldorf Service. Waldorf Astoria Dubai International Financial Centre’s Personal Concierges will ensure that each guest receives anticipatory and personalized service; before, during, and after their stay.

 

Waldorf Astoria Dubai International Financial Centre will participate in Hilton HHonors®, the only guest loyalty program where guests who book directly through www.waldorfastoria.com have access to benefits including a Personal Concierge and complimentary Wi-Fi at 25 Waldorf Astoria hotels worldwide.

 

Learn more about Waldorf Astoria Hotels & Resorts at www.waldorfastoria.com. Media can view renderings of Waldorf Astoria Dubai International Financial Centre and additional information at http://news.waldorfastoria.com/dubaiifc.

 

About Waldorf Astoria Hotels & Resorts

 

Waldorf Astoria Hotels & Resorts is a portfolio of 25 iconic properties in the world’s most sought after destinations. Unified by their inspirational environments and True Waldorf Service, Waldorf Astoria hotels deliver unparalleled, bespoke service from the moment a guest books through check out. Waldorf Astoria is a part of Hilton Worldwide, a leading global hospitality company. Experience Waldorf Astoria by booking at www.waldorfastoria.com. Learn about the brand by visiting http://news.waldorfastoria.com or following the brand on Twitter, Instagram, and Facebook.

 

About Hilton Worldwide

 

Hilton Worldwide (NYSE: HLT) is a leading global hospitality company, comprising more than 4,660 managed, franchised, owned and leased hotels and timeshare properties with nearly 765,000 rooms in 102 countries and territories. For 96 years, Hilton Worldwide has been dedicated to continuing its tradition of providing exceptional guest experiences. The company's portfolio of 13 world-class global brands includes Hilton Hotels & Resorts, Waldorf Astoria Hotels & Resorts, Conrad Hotels & Resorts, Canopy by Hilton, Curio – A Collection by Hilton, DoubleTree by Hilton, Embassy Suites by Hilton, Hilton Garden Inn, Hampton by Hilton, Tru by Hilton, Homewood Suites by Hilton, Home2 Suites by Hilton and Hilton Grand Vacations. The company also manages an award-winning customer loyalty program, Hilton HHonors®. Hilton HHonors members who book directly through preferred Hilton channels have access to benefits including preferred pricing, free standard Wi-Fi, as well as digital amenities that are available exclusively through the industry-leading Hilton HHonors app, where HHonors members can check-in, choose their room, and access their room using a Digital Key. Visit news.hiltonworldwide.com for more information and connect with Hilton Worldwide on Facebook, Twitter, YouTube, Flickr, LinkedIn and Instagram.

 

 

YASH Technologies Achieves ISO 27001:2013 Information Security Management System Certification (ISMS)

Business Wire India
YASH Technologies™, a leading technology services and outsourcing partner for global companies, today announced it has achieved the ISO 27001:2013 Information Security Management System (ISMS) Standard for IT consulting and managed services, including software development, maintenance, and testing.  Upgradation from ISO 27001: 2005 to ISO 27001:2013 is a reaffirmation of YASH’s continued compliance to the highest standards of information security management, and commitment to remaining current and relevant to new age risks and vulnerabilities.
 
The ISO 27001 ISMS Standards is a process approach established and updated by the International Organization for Standardization (ISO), the world’s largest developer of international standards. The ISO 27001:2013 ISMS Standard specifies the requirements for establishing, implementing, maintaining, and continually improving an information security management system (ISMS) for any organization, regardless of type or size.
 
“Increasing IT threats make it even more crucial for organizations to remain compliant with the latest security guidelines and avert risk. The latest certification acknowledges YASH Technologies’ continuous efforts to ensure customers with the highest level of information security, seamless business continuity, and operational excellence,” said Murali Jothilingam, vice president of IMS, YASH Technologies.  “We are delighted to achieve this international accreditation and would like to congratulate our team members for their sheer hard work and dedication, and also our customers and partners for their constant support and faith in YASH,”  he added. 
 
ISO is a network of the national standards institutes for 162 countries and created the standard to set international requirements for quality management systems.

About YASH Technologies
 
YASH Technologies focuses on customer success. As a leading technology services and outsourcing partner for large and fast growing global customers, the company leverages technology and flexible business models to drive innovation and value throughout its customer’s enterprise. YASH customer centric engagement & delivery framework integrates specialized domain and consulting capabilities with proprietary methodologies and solution offerings to provision application, infrastructure and end user focused Right-Sourcing services. YASH is a SEI CMMI (Level 3) and an ISO 9001:2013 certified company with U.S. and India headquarters and regional sales and development offices globally with customers spread across 6 continents. For more information, please visit www.YASH.com or email info@YASH.com.

Redefining the Paradigm of ‘Walk to Work and Walk Back Home’, Hiranandani Business Park, Powai: Niranjan Hiranandani

Business Wire India
The success story of real estate is co-authored by different segments of real estate located within the same real estate hub. The integrated township, Hiranandani Gardens, Powai; which recently celebrated its silver jubilee, also owes its success to different segments other than high-end residential, retail, hospitality, F&B, academic and medical – the segment of ‘office and work spaces’.
 
The success story of office and work spaces within Hiranandani Gardens, Powai – the Hiranandani Business Park – not just redefined the paradigm of ‘walk to work and walk back home’, it also created a template that has been successfully recreated in Hiranandani Estate, Thane; and is in process of being re-created at Hiranandani Fortune City, Panvel. “It is all about creating world-class commercial spaces set within a Green, eco-friendly, mixed-use township,” said Niranjan Hiranandani, MD, Hiranandani Communities.
 
“When it comes to commercial real estate, any success story gets written only if it attracts attention from Global Companies, MNCs and domestic Corporate Entities looking out for commercial real estate which offers global standards of amenities and facilities. Hiranandani Business Park, Powai; did all that, it conceptualized a work culture that went beyond just business,” said Niranjan Hiranandani.
 
For businessmen and corporate entities, the Hiranandani Business Park in Powai has been an epitome of growth and an expression of path breaking innovation, which conceptualized a work culture that goes beyond just business. “It has dove-tailed with other segments of real estate that make up Hiranandani Gardens, Powai; making it a business destination that is not just well planned for workspaces, but is also situated in the midst of a peaceful neighborhoods, with shopping and entertainment – creating what was arguably, Mumbai’s first complete and constructive work ambience, set within a verdant green environment, where one could actually ‘walk to work and walk back home’,” added Niranjan Hiranandani.
 
Over the years, Commercial Space in Hiranandani Business Park, Powai has evolved into a Central Business District (CBD) in its own right, with an IT Park, an SEZ as also commercial and office spaces. It has ended up becoming the centre-point of business in Mumbai’s suburbia. Consider that within a radius of 5 kms around the Hiranandani Business Park, Powai; around 200,000 people report to work every day. Add to that more than 30,000 employees who work out of the Hiranandani Business Park. Plus, consider that it is located in the vicinity of major infrastructure establishments, which defines the location a well-established business destination, and you start to understand what makes it a CBD in its own right. “Hiranandani Business Park, Powai; was created to offer modern luxuries while being surrounded by the verdant greenery, situated a short distance from Powai Lake and amidst picturesque hills, making for the perfect office space located at the heart of nature,” explained Niranjan Hiranandani.
 
This comes along with location-based advantages: SEEPZ and the MIDC are both, a mere 3.5 km away, while large corporate campuses in vicinity include giants like Larsen & Toubro and Godrej. The International terminal of the CSI Airport is 5 km away, the Domestic terminal 12 kms. “The success story of Hiranandani Business Park, Powai has been written on work-spaces with global standards including buildings such as Alpha, Delphi, Fairmont, Sentinel, Winchester, Kensington, Ventura among others,’ said Niranjan Hiranandani. “In Powai, the Hiranandani Business Park has offered scalability to its clients with global architecture trends which include well-decorated entrances and lift lobbies of the buildings, while also offering value added services which include residential lease desk, project management and consultancy,” he added.
 
A successful template that is being recreated in Thane and Panvel, Hiranandani Business Park, Powai; is home to some of India’s most acclaimed and the world’s most revered corporations. “It is truly, among the best success stories of Mumbai’s commercial real estate,” said Niranjan Hiranandani. It provides a complete, responsive and productive work ambience with 24 x 7 work-and-live environment and world-class infrastructure. “It has been the ideal commercial space, offering comprehensive business solutions for enterprises geared to play an eminent role in this integrated world,” he added.
 
Kellogs, TCS, Wipro, Mearsk, Crisil, J.P. Morgan, Creditsuisse, G.E. , Deloitte, British Gas, Transocean, Colgate, General Mills, Petrofac, Basel, Syntel , Nomura, Cognizant, Accenture, Black & Veatch are among the corporate entities that work out of Hiranandani Business Park, Powai.
 
“Hiranandani Business Park, Powai, will not continue to leverage futuristic technology, innovative design and precision engineering; as a template it will result in creating many more such success stories in commercial real estate,” concluded Niranjan Hiranandani.

World Environment Day Celebration at JNPT

Business Wire India
The World Environment Day was celebrated at JNPT, on the occasion, the Chairman Shri Anil Diggikar addressed the gathering, where he emphasise the importance of WED and JNPT’s initiatives to make the Port as green Port and ensure sustainable development. Also seminar and interactive session was held on the environment legal aspects on port and coast. Shri Sanjay Upadhyay, Advocate, Supreme Court and environment expert explained various provisions on environmental issues.
 

The programme was attended by the Shri Naresh Kumar, Chief Manager (Admin.) & Secy. Shri A.K. Bose, Chief Manager (Traffic), Sr. officers and Terminal Operators.

Photo Caption: Shri Anil Diggikar, IAS, Chairman, JNPT, Shri Sanjay Upadhyay, Advocate Supreme Court & Environment Expert and other officials on the occasion of ‘World Environment Day’

GoDaddy Helps Punjab-based Web Services Company Achieve 30% Revenue Growth Annually

Business Wire India
GoDaddy Inc. (NYSE: GDDY), the world’s largest technology provider dedicated to small businesses, today announced that Guava Softs, a Punjab-based web services company, witnessed 30 percent revenue growth per annum since partnering with GoDaddy. GoDaddy continues to grow its reseller network through complementary partnerships that deliver value to small businesses across India.
 
GoDaddy offers its partners a ‘one-stop-shop’ for all relevant products and solutions including access to integrated Web solutions spanning domain registration, email, hosting, website building, marketing tools and aftermarket domain services.
 
Established in 2006 by Mr. Anshul Goyal, Guava Softs became a GoDaddy reseller in January 2011 to help accelerate business growth with the help of a globally recognized and trusted partner. GoDaddy’s expansive suite of integrated products and solutions, competitive prices, dedicated partner support and powerful marketing capabilities were key deciding factors for Guava Softs. The partnership resulted in immediate results for the company, leading to Guava Softs registering more than a thousand domain names within three months. Guava Softs partnered with GoDaddy to execute various joint marketing activities, including campaigns to increase awareness about the availability of new domain name extensions and how they can help businesses create an effective online presence. With GoDaddy’s support, the company has increased its customer base 25 percent every year since the partnership was formed.  
 
“GoDaddy offers several value added services, complementing our business goals and allowing us to better serve our customers,” said Mr. Goyal. “GoDaddy keeps us ahead of the curve with the latest online products and solutions to help small businesses create their digital presence on the Internet. The GoDaddy Partner and Marketing teams also equip us with the tools to help us build a stronger brand and grow our business” he added.
 
“Our goal in India is to help small business owners get an online presence easily and at an affordable cost,” said Rajiv Sodhi, Vice President and Managing Director, GoDaddy India and Australia. “Our partners perform the crucial task of taking our end products to their customers locally, helping us educate them on the inherent benefits of the Internet. We remain committed to building a strong partner ecosystem in India and working closely with them to help small businesses succeed.”
 
Headquartered in Scottsdale, Ariz. USA, GoDaddy also has offices across other locations including in Washington, Massachusetts, Iowa and California in the U.S., and international locations in Australia, Brazil, Canada, India, Mexico, Netherlands, Singapore and in the U.K. 
 
To learn how GoDaddy can help your small business, visit: in.godaddy.com
 
Connect with GoDaddy on Facebook , Twitter & LinkedIn
 
About GoDaddy

GoDaddy's mission is to radically shift the global economy toward small businesses by empowering people to easily start, confidently grow and successfully run their own ventures. With more than 14 million customers worldwide and more than 62 million domain names under management, GoDaddy gives small business owners the tools to name their idea, build a beautiful online presence, attract customers and manage their business. To learn more about the company, visit www.GoDaddy.com
 
© 2016 GoDaddy Inc. All Rights Reserved.

Polycom Wins ‘Video Conferencing Equipment Vendor of the Year’ Award at the 2016 Frost & Sullivan India ICT Awards

Business Wire India
Polycom was named the ‘Video Conferencing Equipment Vendor of the Year’, at the 2016 Frost & Sullivan India ICT Awards banquet held on June 2nd at Hyatt Regency, Mumbai.
 
Polycom has been growing progressively in the Indian video conferencing market over the last few years and has provided superior video collaboration solutions for business use. Understanding customer demands and delivering a superior experience enabled the company to capture customer delight.  The company catered to every enterprise segment with its unique offerings and enhanced value proposition. Its commitment to constantly innovate was visible through its new product launches, leading to its growth journey.
 
Speaking on this occasion, Mr. Minhaj Zia, Vice President India SAARC and South Korea for Polycom said “Work has drastically changed from a place we go to – into something that we do, irrespective of time, location and devices we use. In order for collaboration and teamwork to thrive in the workplace of the future, organizations need the right tools. Our solutions help unleash the power of human collaboration across any distance, device, or timeline to help not only save costs and meet company objectives, but to create a true Workplace of the Future. For the past several years, Polycom has focused on changing our customers’ experience of video collaboration and enabling the workplace of the future. We make sure the solutions we bring to market are simplified for an improved user experience and easier adoption and today we are proud to be the recipient of this award”

Extending hearty congratulations to Polycom on winning the 2016 Video Conferencing Equipment Vendor of the Year award, Mr. Benoy CS, Director, Digital Transformation Practice, Frost & Sullivan said, “Polycom is a key innovator in the video conferencing market in India and has achieved exemplary revenue growth of 22%. The company’s continued investments in technology backed by a strong go-to-market strategy have given it a competitive edge. The vendors focus on enhancing the end user customer experience has been instrumental, leading to acquisition of many new customers. Through strategic partnerships with leading unified communication solutions provider it offers cloud-based collaboration solutions leading to seamless communications for the enterprise.”

The award recipients were judged on a variety of parameters that included revenue growth, market share growth, product portfolio diversity, key achievements, and Go-to-Market strategy. It involved in-depth primary interviews of various industry participants and secondary research conducted by Frost & Sullivan analysts. An elite panel of jury members comprising prominent CIOs/CTOs from the industry evaluated the compiled data and incorporated the end-user perspective. Frost & Sullivan then presented the Awards to companies that received the highest industry rank in each category.
 
About Polycom

Polycom helps organisations unleash the power of human collaboration. More than 400,000 companies and institutions worldwide defy distance with secure video, voice and content solutions from Polycom to increase productivity, speed time to market, provide better customer service, expand education and save lives. Polycom and its global partner ecosystem provide flexible collaboration solutions for any environment that deliver the best user experience, the broadest multi-vendor interoperability and unmatched investment protection. Visit www.polycom.co.in or connect with us on Twitter, Facebook and LinkedIn or the Polycom Asia Pacific blog, www.polycom.asia/theview, to learn more.
 
About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. 
 
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
 

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including research, analysis, strategy, vision, innovation and implementation.  
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible.  This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.  

 
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?  
 
Contact Us: Start the discussion

Website: http://www.frost.com
 
Twitter: @Frost_MENASA

Twitter: @PolycomAPAC

Photo Caption: Mr. Minhaj Zia, Vice President, India, SAARC & Korea, Polycom receiving the 'Video Conferencing Equipment Vendor of the Year' award from Mr. Vikram Idnani, CIO, Trent Limited, in the presence of Mr. Y. S. Shashidhar, Managing Director & Partner, MENASA, Frost & Sullivan